Abiopharma

🔍 King David Lee (Executive)

Company: Primoris Services Corp (PRIM)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 268 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 34,941.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The non-employee director compensation program adopted by the Board in May 2011 and updated July 2024, provides for the issuance of restricted stock with a value of $37,500. The price per share was based on the average closing price during March 2026, resulting in a grant of 268 shares of stock. The shares of stock cannot be sold for a period of twelve months from the date of grant.